Visivra Official Website › Disclaimer
DisclaimerVisivra Disclaimer
Visivra Team at Govisivra · physician review: Dr. Preston Sullivan, MD · last revised
This is a dietary supplement, not a drug, and this website is product information rather than medical advice.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. Sight that has changed is a reason to book an eye examination.
Every formal statement this website makes, gathered in one place so none of them has to be hunted for at the foot of a page.
The FDA statement on Visivra
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.Printed on the front panel
That sentence is printed on the artwork and it is reproduced on every page of this website. It means what it says: no agency has reviewed the claims made for this product, and no dietary supplement is FDA-approved, because the agency does not approve supplements.
An FDA-registered facility, which is one of the marks on this artwork, is a statement about a building being on a register. It is not an inspection result and it is not an endorsement of anything made there.
What Visivra is not for
It does not treat, prevent or slow macular degeneration. It does not treat cataract. It does not treat glaucoma. It does not restore sight that has been lost. It does not change a spectacle or contact lens prescription. And it is not a reason to postpone an eye examination, which is where every condition on this list is actually found.
The four claims this product does make are printed on the pack, reproduced on the benefits page, and examined there against the research one at a time. They are the ceiling on everything this website says.
Visivra and your eye doctor: when to go first
Visivra is a dietary supplement. It does not diagnose or treat any eye condition, and it is not a substitute for an eye exam, glasses, prescribed drops or any other treatment.
Go today
Sudden vision loss, even for a few minutes; a sudden burst of floaters; flashes of light; or a shadow or curtain across part of your sight. These can signal a retinal tear or detachment, which needs urgent treatment. Source: National Eye Institute, retinal detachment.
Go soon
An eye that hurts, is red, or has become sensitive to light, especially with blurred vision. Source: MedlinePlus, eye pain.
With diabetes
Diabetic eye disease can progress with no symptoms. A comprehensive dilated eye exam at least once a year is the advice, along with keeping blood sugar, blood pressure and cholesterol in range. Source: NIDDK, diabetic eye disease.
With glaucoma or a family history
Glaucoma usually has no early warning signs. Keep your checks and keep using any drops you have been prescribed; a supplement does not lower eye pressure. Source: NEI, glaucoma.
For everyone
Regular eye exams, sunglasses outdoors, not smoking and a current prescription do more for long-term eye health than any capsule. Sources: NEI, keep your eyes healthy and NEI, dilated eye exams.
With other supplements or medicines
Zinc and vitamin A are named on the artwork without amounts. Show the bottle to a pharmacist if you take an AREDS2-type vitamin, a multivitamin, zinc or prescription medicine. Sources: NIH Office of Dietary Supplements, zinc and FDA, questions and answers on dietary supplements.
Sudden changes in sight are an emergency. If you have diabetes, glaucoma or a family history of eye disease, your scheduled dilated exams come first, whether or not you take Visivra. A bad reaction to any supplement can be reported to the FDA through MedWatch.
Results, reviews and figures on the Visivra website
- Individual results vary. Sleep, light, screen habits and a current spectacle prescription move the same things this formula is sold to support.
- Reviews here are buyer-supplied and summarised by this desk. They are not verified transcripts, they are not typical and they are not evidence.
- The rating, the review count and the order count are this desk’s own figures. Other desks selling this bottle keep their own and they will differ.
- Trial amounts quoted anywhere on this website belong to the trials they came from. This product is not those formulas and inherits none of their findings.
- Lot VIS-26/GO-1787 and certificate reference VIS-1787-26-GO are filing references, not laboratory proof.
Audience and cautions for Visivra
For healthy adults aged 18 and over. Not for under-18s, or for anyone pregnant or nursing.
Two rows on this label depend on a figure the seller holds. Anyone who smokes or used to should establish which form of vitamin A the capsule uses before taking it, and anyone already taking a zinc tablet, a multivitamin or an AREDS2 product is stacking amounts that cannot be seen from this side. Both are set out on the side effects page.
A new visual symptom is an appointment rather than a question for a supplement website, and several of the possible causes are time-sensitive.
Affiliation and the Visivra channel
Govisivra is the licensed U.S. retail desk for Visivra and is a retailer rather than the manufacturer. Orders placed through the button on this website are completed on the seller’s checkout, and this desk is compensated on completed orders.
That is stated plainly because it explains why the website exists. It does not change what is printed here: the label gives six names and no amounts, and every page on this website says so.
How research is cited on this Visivra website
Forty-one sources are cited across these pages and the rules governing them are worth stating, because a citation is the easiest thing on a supplement website to fake.
- Every record was retrieved from the source database itself. The title, the authors, the journal, the year and the pages were read out of the record rather than typed from memory.
- Every link goes to the record, not to a summary of it or to a page describing it.
- Every source in a foot-of-page list also appears inline, in the sentence that relies on it. A reference list nobody cites in the body is decoration.
- Where a study could not be retrieved, it is not cited. Two sets of widely quoted studies in this category are absent from this website for that reason and the absence is explained where it matters.
- A trial amount quoted anywhere here belongs to the trial it came from. It is never presented as a property of this capsule.
The last rule is the one that shapes this website. Six actives are named on the artwork and no amount is given for any of them, so every comparison with a published dose is a comparison with an empty column, and each page that makes one says so in the same sentence.
External links from the Visivra website
Links here fall into two groups and they are treated differently.
Research links open public databases and institutional pages. This desk has no relationship with any of them, no control over what they publish, and no ability to keep them online. They are cited for what their records contain. Every one carries the attributes that tell a search engine this desk is not vouching for the destination commercially.
The order link opens the seller’s checkout. That one is commercial, this desk is compensated on completed orders, and it is marked as such in the markup as well as stated in words on the about page.
No link on this website has been paid for by a third party, and no page here carries advertising. If that ever changes it will be stated on this page before it happens rather than afterwards.
Where the Visivra facts on this website come from
Three sources, and where they disagree this website says which one it followed rather than smoothing it over.
| Source | What it settles | Read on |
|---|---|---|
| The product artwork | The six named actives, the capsule count, the four printed claims and the FDA line | The eighteen files in this desk’s asset pack |
| The seller’s own page | The pack ladder, the prices, the shipping and the guarantee | 19 September 2026 |
| This desk’s paperwork | The lot, the certificate reference, the addresses and the order line | Held here |
Where the artwork and the seller’s page differ, the artwork wins and the difference is recorded rather than resolved quietly.
The published research is a fourth kind of source and is treated differently from the other three. It is cited for what it measured, in whom and over how long, never as a statement about this capsule, because this label gives no amount to set beside any trial figure.
One example is worth giving, because it is the sort of thing a reader cannot check from the outside. The guarantee on this website runs sixty days from the date of purchase, and that is the figure printed in this desk’s own pack and on the seller’s page. Purchase is earlier than dispatch, so the window is already running while the parcel is in the post: the days between paying and the first capsule are days of it already spent. That is why every page here recommends diarising day fifty rather than day sixty, and it is a detail a summary written from a different seller’s terms would get wrong in the direction that costs a buyer money.
If anything on this website conflicts with what the seller states on your own order, the seller’s terms are the ones that bind, and the order desk, with the order ID, is how to establish which applies.
The claims ceiling on every Visivra page
Everything on this website sits inside one boundary, and it is worth setting out where the boundary is rather than leaving each page to imply it.
| Kind of statement | Permitted here | Example from this website |
|---|---|---|
| A structure and function claim | Yes, up to the four printed on the pack | Supports visual clarity |
| A description of what an ingredient is | Yes | Lutein is a carotenoid the macula concentrates |
| A report of what a trial measured | Yes, attributed to the trial and to its population | AREDS2 gave 10 mg of lutein a day for five years |
| A claim that this product inherits a trial result | No | Nowhere on this website |
| A disease claim | No | Nowhere on this website |
| A promised outcome or timeline | No | The timeline pages describe what trials measured, not what will happen |
The first row is the ceiling. Rows two and three are how a page adds depth without raising it, and rows four to six are what a supplement website is not permitted to say and this one does not.
That table is the reason the ingredients page prints trial amounts beside an empty column rather than nearby and unremarked. Setting a figure next to a product and leaving the reader to connect them is the same claim as making it out loud, and it is made no better by being implied.
A fifth support appears on the seller’s information site, about reducing the oxidative stress associated with eye fatigue. It is not on the pack’s list, this desk cannot support it from the sources it cites, and it therefore appears nowhere on these pages.
